DANIA MANIGAT: Open Payments
NPI 1336750793 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 56 payments from 21 companies in 2025. Trend: 2023 $765 · 2024 $1,523 · 2025 $1,375
Food & beverage: $1,375
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $295 |
| Novo Nordisk Inc | 4 | $158 |
| Amneal Pharmaceuticals LLC | 4 | $88 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $87 |
| CeQur Corporation | 1 | $82 |
| Ascendis Pharma Endocrinology Inc | 3 | $78 |
| Xeris Pharmaceuticals, Inc. | 4 | $77 |
| Medtronic, Inc. | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| SANOFI-AVENTIS U.S. LLC | 2 | $59 |
Products named: TEPEZZA, Ozempic, UNITHROID, ISTURISA, CeQur Simplicity, Yorvipath, GVOKE HYPOPEN, JARDIANCE.
Industry payments across FL — which companies pay providers there.
